新闻发布会上
查看打印版本 |
<<回来 |
开创性注册旨在帮助研究人员加快COVID-19诊断、治疗和预防策略
本新闻稿以多媒体为特色。在这里查看完整版本:https://www.businesswire.com/news/home/20200409005379/cn/
“医疗保健从业者和研究人员需要对Covid-19的动态和实时见解,以解决这种医疗保健危机,为患者提供更好的治疗方案,”
最初,
Ciox能够安全、安全、有效地获取和管理临床数据
这一数据集将在未来几周和几个月扩大规模,汇集与继续研究这一至关重要的医学和公共卫生领域有关的数百万个数据点。这些队列预计将有助于深入了解导致对SARS-CoV-2病毒感染易感性或免受感染的可能宿主和环境因素,以及与发病时疾病严重程度相关的危险因素和基于干预的相关结果。关于COVID-19在不同人群中的病程以及如何改变其发展轨迹的许多其他问题也可以使用这个数据集来回答。
“登记处将使研究人员和临床医生能够从真实世界中获得快速的见解,并具有改善Covid-19的治疗和预防的最终目标。这项重要的工作直接谈到Labcorp的使命,以改善健康和改善生活,“
科恩用作患者数据登记处的共同调查员。
关于
了解更多信息
关于Ciox
Ciox真实世界数据部门(Ciox RWD)利用其DataFit平台™,协助供应商安全地、持续地管理不同的数据集,使研究人员能够访问有价值的临床信息,否则可能隐藏在或跨工作流系统的不同部分,存放医疗记录。Ciox DataFit平台利用基于临床规则的医学概念转换和非结构化数据集,构建可供研究人员使用的高度结构化的临床数据。学习更多在www.cioxrwd.com..
关于前瞻性声明的警示性声明
本新闻稿载有前瞻性陈述,包括但不限于我们对我们的回复以及Covid-19大流行,战略伙伴关系和科学合作的预期对未来影响的陈述,这些伙伴关系和合作的预期福利,以及expected impact that the various partnerships and collaborations may have on the Company’s financial results. Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the Company’s control, including without limitation, the impact of the COVID-19 pandemic on our business and financial condition, as well as on general economic, business, and market conditions, and the Company’s ability to establish and maintain strategic partnerships and other scientific collaborations. These factors, in some cases, have affected and in the future (together with other factors) could affect the Company’s ability to implement the Company’s business strategy and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. The Company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the Company’s most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in the Company’s other filings with the
# # #
查看源版本businesswire.com:https://www.businesswire.com/news/home/20200409005379/cn/
LabCorp联系人:
媒体:
media@labcorp.com.
投资者:
Investor@labcorp.com.
Ciox联系人:
媒体:
media@cioxrwd.com
来源: